- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 53,803,111
- Total 13F shares
- 35,239,863
- Share change
- -460,050
- Total reported value
- $267,821,738
- Put/Call ratio
- 24%
- Price per share
- $7.60
- Number of holders
- 45
- Value change
- -$5,207,345
- Number of buys
- 15
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 90240B106?
CUSIP 90240B106 identifies TYRA - Tyra Biosciences, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 90240B106:
Top shareholders of TYRA - Tyra Biosciences, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
13%
|
7,236,454
|
$63,609,000 | — | 30 Sep 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
12%
|
6,448,359
|
$56,681,000 | — | 30 Sep 2022 | |
| Canaan Partners XI LLC |
13F
|
Company |
8.2%
|
4,409,991
|
$38,764,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
7.5%
|
4,026,301
|
$35,391,000 | — | 30 Sep 2022 | |
| Alta Partners NextGen Fund II Management, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,080,296
|
$26,844,267 | — | 17 Sep 2021 | |
| Nextech Invest Ltd. |
13F
|
Company |
4.7%
|
2,518,582
|
$22,138,000 | — | 30 Sep 2022 | |
| BVF INC/IL |
13F
|
Company |
4.6%
|
2,472,327
|
$21,732,000 | — | 30 Sep 2022 | |
| Fairmount Funds Management LLC |
13F
|
Company |
2.6%
|
1,416,998
|
$12,455,000 | — | 30 Sep 2022 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.5%
|
1,327,665
|
$11,670,000 | — | 30 Sep 2022 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1.8%
|
945,707
|
$8,313,000 | — | 30 Sep 2022 | |
| Cormorant Asset Management, LP |
3/4/5
13F
|
Former 10% Owner · Company |
1.4%
from 13F
|
1,069,932
|
$7,039,083 | — | 17 Sep 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.3%
|
682,018
|
$6,009,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
622,098
|
$5,468,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
599,953
|
$5,274,000 | — | 30 Sep 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.92%
|
494,403
|
$4,346,000 | — | 30 Sep 2022 | |
| Canaan XI L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
473,396
|
$3,114,472 | — | 17 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
247,450
|
$2,175,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.45%
|
241,099
|
$2,119,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
219,547
|
$1,930,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.41%
|
217,988
|
$1,916,000 | — | 30 Sep 2022 | |
| Robert L. Hudkins |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
273,576
|
$1,799,857 | — | 15 Sep 2022 | |
| Ronald Swanson V |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
378,254
mixed-class rows
|
$1,797,738 | — | 06 Sep 2022 | |
| Esther van den Boom |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
240,542
|
$1,582,525 | — | 15 Sep 2022 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.28%
|
152,159
|
$1,337,000 | — | 30 Sep 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.24%
|
127,316
|
$1,119,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
103,808
|
$912,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
96,175
|
$846,000 | — | 30 Sep 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.16%
|
85,182
|
$748,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
40,619
|
$357,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
39,250
|
$345,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.06%
|
34,886
|
$307,000 | — | 30 Sep 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
20,633
|
$181,000 | — | 30 Sep 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.04%
|
20,000
|
$176,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
18,756
|
$165,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
13,791
|
$121,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
12,512
|
$110,000 | — | 30 Sep 2022 | |
| Sepio Capital, LP |
13F
|
Company |
0.02%
|
10,625
|
$93,000 | — | 30 Sep 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
10,525
|
$93,000 | — | 30 Sep 2022 | |
| FISHMAN JAY A LTD/MI |
13F
|
Company |
0.02%
|
10,500
|
$92,295 | — | 30 Sep 2022 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,231
|
$55,000 | — | 30 Sep 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
5,180
|
$46,000 | — | 30 Sep 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
4,922
|
$43,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
4,203
|
$37,000 | — | 30 Sep 2022 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
1,621
|
$14,000 | — | 30 Sep 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,405
|
$12,000 | — | 30 Sep 2022 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
940
|
$8,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
556
|
$5,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
200
|
$2,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
160
|
$1,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
91
|
$1,000 | — | 30 Sep 2022 |
Institutional Holders of Tyra Biosciences, Inc. - COMMON STOCK (TYRA) as of Q4 2022
As of 31 Dec 2022,
Tyra Biosciences, Inc. - COMMON STOCK (TYRA) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,239,863 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Boxer Capital, LLC, Canaan Partners XI LLC, FMR LLC, Nextech Invest Ltd., BVF INC/IL, TCG Crossover Management, LLC, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., and BlackRock Inc..
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
43
Q4 2022 holders
45
Holder diff
2
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.